Literature DB >> 35768589

COVID antibody drugs have saved lives - so why aren't they more popular?

Asher Mullard.   

Abstract

Entities:  

Keywords:  Drug discovery; Immunology; SARS-CoV-2

Mesh:

Substances:

Year:  2022        PMID: 35768589     DOI: 10.1038/d41586-022-01735-7

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Combination anti-HIV antibodies provide sustained virological suppression.

Authors:  Michael C Sneller; Jana Blazkova; Susan Moir; Tae-Wook Chun; J Shawn Justement; Victoria Shi; Brooke D Kennedy; Kathleen Gittens; Jekaterina Tolstenko; Genevieve McCormack; Emily J Whitehead; Rachel F Schneck; Michael A Proschan; Erika Benko; Colin Kovacs; Cihan Oguz; Michael S Seaman; Marina Caskey; Michel C Nussenzweig; Anthony S Fauci
Journal:  Nature       Date:  2022-06-01       Impact factor: 69.504

2.  Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.

Authors:  Laura L Hammitt; Ron Dagan; Yuan Yuan; Manuel Baca Cots; Miroslava Bosheva; Shabir A Madhi; William J Muller; Heather J Zar; Dennis Brooks; Amy Grenham; Ulrika Wählby Hamrén; Vaishali S Mankad; Pin Ren; Therese Takas; Michael E Abram; Amanda Leach; M Pamela Griffin; Tonya Villafana
Journal:  N Engl J Med       Date:  2022-03-03       Impact factor: 176.079

3.  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.

Authors:  Dora Pinto; Young-Jun Park; Martina Beltramello; Alexandra C Walls; M Alejandra Tortorici; Siro Bianchi; Stefano Jaconi; Katja Culap; Fabrizia Zatta; Anna De Marco; Alessia Peter; Barbara Guarino; Roberto Spreafico; Elisabetta Cameroni; James Brett Case; Rita E Chen; Colin Havenar-Daughton; Gyorgy Snell; Amalio Telenti; Herbert W Virgin; Antonio Lanzavecchia; Michael S Diamond; Katja Fink; David Veesler; Davide Corti
Journal:  Nature       Date:  2020-05-18       Impact factor: 49.962

4.  Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.

Authors:  Myron J Levin; Andrew Ustianowski; Stéphane De Wit; Odile Launay; Miles Avila; Alison Templeton; Yuan Yuan; Seth Seegobin; Adam Ellery; Dennis J Levinson; Philip Ambery; Rosalinda H Arends; Rohini Beavon; Kanika Dey; Pedro Garbes; Elizabeth J Kelly; Gavin C K W Koh; Karen A Near; Kelly W Padilla; Konstantina Psachoulia; Audrey Sharbaugh; Katie Streicher; Menelas N Pangalos; Mark T Esser
Journal:  N Engl J Med       Date:  2022-04-20       Impact factor: 176.079

5.  REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.

Authors:  David M Weinreich; Sumathi Sivapalasingam; Thomas Norton; Shazia Ali; Haitao Gao; Rafia Bhore; Jing Xiao; Andrea T Hooper; Jennifer D Hamilton; Bret J Musser; Diana Rofail; Mohamed Hussein; Joseph Im; Dominique Y Atmodjo; Christina Perry; Cynthia Pan; Adnan Mahmood; Romana Hosain; John D Davis; Kenneth C Turner; Alina Baum; Christos A Kyratsous; Yunji Kim; Amanda Cook; Wendy Kampman; Lilia Roque-Guerrero; Gerard Acloque; Hessam Aazami; Kevin Cannon; J Abraham Simón-Campos; Joseph A Bocchini; Bari Kowal; A Thomas DiCioccio; Yuhwen Soo; Gregory P Geba; Neil Stahl; Leah Lipsich; Ned Braunstein; Gary Herman; George D Yancopoulos
Journal:  N Engl J Med       Date:  2021-09-29       Impact factor: 176.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.